Evaluation of in vivo T cell kinetics: use of heavy isotope labelling in type 1 diabetes.
about
In vivo kinetics and nonradioactive imaging of rapidly proliferating cells in graft-versus-host diseaseComparing DNA enrichment of proliferating cells following administration of different stable isotopes of heavy water.Obstacles and opportunities for targeting the effector T cell response in type 1 diabetes.Cells with Treg-specific FOXP3 demethylation but low CD25 are prevalent in autoimmunity
P2860
Evaluation of in vivo T cell kinetics: use of heavy isotope labelling in type 1 diabetes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Evaluation of in vivo T cell kinetics: use of heavy isotope labelling in type 1 diabetes.
@en
Evaluation of in vivo T cell kinetics: use of heavy isotope labelling in type 1 diabetes.
@nl
type
label
Evaluation of in vivo T cell kinetics: use of heavy isotope labelling in type 1 diabetes.
@en
Evaluation of in vivo T cell kinetics: use of heavy isotope labelling in type 1 diabetes.
@nl
prefLabel
Evaluation of in vivo T cell kinetics: use of heavy isotope labelling in type 1 diabetes.
@en
Evaluation of in vivo T cell kinetics: use of heavy isotope labelling in type 1 diabetes.
@nl
P2093
P2860
P356
P1476
Evaluation of in vivo T cell kinetics: use of heavy isotope labelling in type 1 diabetes.
@en
P2093
C J Greenbaum
J B Bollyky
J H Buckner
M K Hellerstein
P L Bollyky
P L Samuels
P2860
P304
P356
10.1111/CEI.12064
P577
2013-06-01T00:00:00Z